Abstract
AbstractThis work aims to detect the Mucin‐1 (MUC1) breast cancer biomarker using a label‐free impedimetric biosensor of silver molybdate anchored on reduced graphene oxide (Ag2MoO4‐rGO). A hydrothermal method has been employed to synthesize the Ag2MoO4‐rGO nanocomposite. Subsequently, they have been studied through analytical characterization techniques to study the electrocatalytic activity, electroactive surface area, surface functionalities, and morphologies to determine the suitability of the material for biosensor fabrication. Results reveal that the Ag2MoO4‐rGO nanocomposite possesses excellent electroconductivity and surface properties that have significant characteristics for the biosensor's performance. A biosensor has been fabricated by the immobilization of Ag2MoO4‐rGO nanocomposite and anti‐MUC1 antibody on a glassy carbon electrode. The electroanalytical studies revealed that the biosensor has excellent sensitivity and detection performance having a wide linearity of 100 fg mL−1–5 ng mL−1 and a low limit of detection of 2.70 fg mL−1. Moreover, the remarkable selectivity, reproducibility, stability, and detection in serum samples determine the high performance of the biosensor. Therefore, the presented biosensor could be a promising diagnostic tool that shows the remarkable potential to efficiently detect the breast cancer MUC1 biomarker in patient's serum samples.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
